Introduction to pharmacology Dr. Sema Güler Pharmacology what is pharmacology • It is the science that studies what drug molecules do to a living organism and what the organism does to drug molecules. • It acts as a bridge between biology and therapy. Pharmacology Pharmacology is a branch of science that study of Effects of drugs Properties of drugs Their use in treatment Drug effects at the molecular level History • People have been interested in the science of pharmacology since the Antiquity. • They got rid of disease and pain by using the flowers, leaves and roots of some plants in nature. • They increased their working power by chewing coca leaves. People who use opium to relieve their pain unconsciously laid the foundation for pharmacology. Ebers Papirüsü • The first systematic information about medicines was extracted from the Ebers papyri written in Egypt. • Inscriptions from the Sumerian and Egyptian periods also contain information about opium and other medicinal plants. BRANCHES OF PHARMACOLOGY • Pharmacokinetics: It is the science that examines the absorption, distribution, metabolism and excretion of drugs in vivo. • Pharmacodynamics: It is the science that studies the physiological and biochemical effects and mechanisms of action of drugs in living things. • Pharmacotherapy: It is the science that studies the use of drugs in the prophylaxis and treatment of diseases. • Molecular pharmacology: It is the science that studies the interactions between biological systems and drugs in living things at the molecular level. • Biochemical pharmacology: It is the science that studies the interactions between drugs and enzymes. Pharmacotherapy • It is the science that deals with the use of drugs in the prophylaxis and treatment of diseases and their clinical application. • There are several types of treatment. These; ➢ Empirical treatment; It is observation trial without knowing the cause of the disease and the effect of the drug. ➢ Symptomatic (palliative) treatment; It is treatment with drugs to relieve symptoms without removing the cause of the disease. • Prophylactic treatment; drug applications to prevent diseases. • Substitution therapy (replacement); It is the application of drugs to eliminate the deficiency of substances in the body. • Radical treatment (rational); It is the complete elimination of the cause of the disease with medication. Clinical pharmacology: • It is a science that examines the application and evaluation of results which chemical substances examined in experimental animals for the purpose of finding and developing new drugs in normal and sick people. • Clinical pharmacology has developed to better reveal the effects and outcome of drugs in a normal or pathological person. Toxicology: It is a branch of science that examines poisoning caused by drugs or other chemical substances, the structure of toxic substances, properties, mechanisms , action and symptoms of poisoning and treatments of poisonous substances. Pharmacokinetics Pharmacokinetics is the aspect of pharmacology dealing with how drugs reach their site of action and are removed from the body. It examines what the organism does to the drug molecule. Absorption Distribution Metabolism Elimination Pharmacodynamics • Pharmacodynamics is the study of a drug's molecular, biochemical, and physiologic effects or actions • Pharmacodynamics describes the intensity of a drug effect in relation to its concentration in a body fluid, usually at the site of drug action. • It can be simplified to 'what the drug does to the body' • BIOPHARMACY: It examines the factors affecting the absorption of drugs taken into the organism. • Pharmacopeia- Codex • The official book containing the qualitative and quantitative analysis methods of the active and auxiliary substances used in the production of drugs, and the national and international rules and methods that must be followed legally and scientifically. DRUG • "Every medicine is poison, there is no substance that is not poison; It is the dose that separates the drug from the poison. " Paracelsus • WHO (World Health Organization) defines the drug as; ❑"It is a substance that can be used to modify or study physiological systems or pathological states for the benefit of the field." • A drug molecule exerts effect the organism by imitating a neurotransmitter or hormone Placebo • It is a drug form that is similar to the active drug in terms of properties such as color, shape and odor, but does not contain any active substance and has no pharmacological effect. it will be good for me But these drugs are addictive drugs No, I've been using it for 28 years, never did SOURCES OF DRUGS Treatment classification according to the intended use • 1. Preventive (prophylactic) treatment: It is the administration of a drug to a healthy person in order to prevent a possible disease or to temporarily change a physiological event. • 2.Complementary (replacement) therapy: It is the application of drugs to complete the deficiency caused by a deficiency in the organism. • 3. Radical Treatment: It is the application of drugs for the cause of the disease. • 4. Symptomatic treatment (palliative treatment): It is the application of drugs only to reduce the pathological disorders without eliminating the cause of the disease. Basic concepts about drug • Dose: the amount of medicine that you should take at one time • Drug(Drog): raw or semi-raw material obtained by collecting, used in pharmacy and partially in industry • Daily dose:recommended amount of medication during the day • Side effect: is usually regarded as an undesirable secondary effect which occurs in addition to the desired therapeutic effect of a drug or medication. • İndication" for a drug refers to the use of that drug for treating a particular disease. For example, diabetes is an indication for insulin • Contraindication is a specific situation in which a drug not be used because it may be harmful to the person. The three broad name classifications of drugs are as follows: 1. Common name (generic=international common nomenclature): The general name is used to provide international scientific partnership in the field of health and to make scientific publications easy to understand. Example: Acetylcysteine (mucolytic = liquefies, dilutes mucus) 2. Proprietary/brand/trade name: These are names given to the drug by the manufacturing and marketing company. The innovator company can then exclusively market and sell this “brand-name” product during the patent protection period. Copyright laws prevent any other person from using the brand name example: Dikloron, Difenak, Voltaren, Miyadren v.b. • All drugs are analgesic, anti-inflammatory, • drugs used as antirheumatic 3. Chemical/molecular/scientific name: It depicts the chemical/ molecular structure of the drug and states the structure in terms of atoms and molecules accompanied by a diagram of the chemical structur Drug Equivalents • Pharmaceutical Equivalence: Two different preparations contain the same molar amount of the same active substance or substances in pharmaceutical forms (tablet-capsule, ampoule-vial) conforming to the same or comparable standards. • Therapeutic Equivalence: The state of a preparation containing the same active substance as another preparation whose efficacy and safety has already been established, and clinically demonstrating the same efficacy and safety. • Approved drug products are considered to be therapeutic equivalents if they are pharmaceutical equivalents for which bioequivalence has been demonstrated, and they can be expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labeling. *same bioavaibility *same therapeutic effect • Bioequivalence: Two pharmaceutically equivalent preparations are so similar that, after administration at the same molar dose, their bioavailability (in terms of rate and degree of absorption) and thus their therapeutic effects are the same in terms of both efficacy and safety. • When two formulations of the same drug or two drug products are claimed bioequivalent, it is assumed that they will provide the same therapeutic effect or that they are therapeutically equivalent. In this case, most people interpret that they can be used interchangeably. Pharmacokinetics • The study of the disposition of a drug • The disposition of a drug includes the processes of ADME Absorption Distribution Metabolism Excretion Elimination 1. Absorption The rate at which drug molecules reach the bloodstream after entering the organism largely depends on the route of administration Oral It crosses the epithelial tissue and enters the Skin (percutaneous) extracellular fluid. After dispersion, it passes through the Rectal capillary wall and reaches the bloodstream Lung Injection epithelial tissue IV- directly into the bloodstream absent Gastrointestinal Absorption • Most drugs undergo gastrointestinal absorption. Absorption occurs mostly in the duodenum. This is extent to which drug is absorbed from gut lumen into portal circulation • Exception: IV drug administration oral tablet takes about 5-6 hours to pass through the gastrointestinal tract. About 0.5-1 hour of this time in the stomach, the rest of the time passes at intestines The drug through the membranes of the digestive tract; Passive diffusion Active transport Facilitated diffusion Pinocytosis Receptor-mediated endocytosis • It is absorbed by these mechanisms. First-pass hepatic metabolism (presystemic elimination): • When a drug is absorbed from the GI tract, it enters the portal circulation before entering the systemic circulation • If the drug is rapidly metabolized in the liver or gut wall during this initial passage, the amount of unchanged drug entering the systemic circulation is decreased. This is referred to as first-pass metabolism. (Except for drugs administered sublingually and rectum) • [Note: First-pass metabolism by the intestine or liver limits the efficacy of many oral medications. Enterohepatic cycle Drugs that are eliminated via the bile after hepatic first pass may be metabolized in the intestine and pass through the intestinal walls before being excreted in the faeces. They can be reabsorbed. In this way, the re-entry of the drug molecule into the circulation is called the enterohepatic cycle. (digitoxin, steroid, morphine) Bioavailability • Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg is absorbed unchanged, the bioavailability is 0.7% or 70%. • Determining bioavailability is important for calculating drug dosages for non intravenous routes of administration In IV injection 100% absorption 100% bioavailability DRUG DISTRIBUTION Drug distribution is the process by which a drug reversibly leaves the bloodstream and enters the extracellular fluid and tissues. For drugs administered IV, absorption is not a factor, and the initial phase immediately following administration represents the distribution phase, during which the drug rapidly leaves the circulation and enters the tissues Physiological fluid compartments in which drugs are distributed • The distribution of a drug from the plasma to the interstitium depends on • Cardiac output and local blood flow, • Capillary permeability, • Tissue volume, • Degree of binding of the drug to plasma and tissue proteins, • Relative lipophilicity of the drug. The movement of drug from the blood to and from the tissues Drug concentrations in serum after a single injection of drug. Assume that the drug distributes and is subsequently eliminated. • Binding to plasma proteins (bound complex cannot reach tissues and exert its pharmacological effect) • Distribution to tissues (drug must cross cell membrane) • Distribution to the central nervous system • Feto-placental distribution ELIMINATION Elimination: The irreversible removal of the parent drugs from the body Elimination from the kidneys Elimination through digestion Elimination through the lung Elimination via milk (for lactating women) Elimination through sweat With all secretions in the body (tears, genital secretions..) Elimination Excretion Drug Metabolism (Biotransformation The biotransformation of drugs • Relative contribution of cytochrome P450 (CYP) isoforms to drug biotransformation • Phase I reactions utilizing the P450 system: • The phase I reactions most frequently involved in drug metabolism are catalyzed by the cytochrome P450 system. • The P450 system is important for the metabolism of many endogenous compounds (such as steroids and lipids) and for the biotransformation of exogenous substances (drugs, carcinogens, and environmental pollutants). • Cytochrome P450 (CYP) is a superfamily of heme-containing isozymes located in most cells, but primarily in the liver and GI tract. • Phase II: This phase consists of conjugation reactions. • If the metabolite from phase I is sufficiently polar, it can be excreted by the kidneys. • However, many phase I metabolites are still too lipophilic to be excreted. • A subsequent conjugation reaction with an endogenous substrate, such as glucuronic acid, sulfuric acid, acetic acid, or an amino acid, results in polar, usually more water soluble compounds that are often therapeutically inactive and more water-soluble metabolite which are readily excreted in urine or bile. Pharmacodynamics EXAMINES THE EFFECTS OF DRUGS ON THE ORGANISMS. • Drug molecules enter the organism and create desired (therapeutic) and undesirable effects (side effects and toxic effects). Adverse effect: • The most important feature desired in the drug is that it affects only the diseased structures and has minimal or no effect on other parts of the body. • There is hardly any such drug. • Although liver necrosis, nephritis and pancreatitis caused by paracetamol overdose are called toxic effects, less harmful skin rashes and hematological changes can be named as side effects. FACTORS CHANGING THE EFFECT OF DRUGS • Weight • Age • Kidney failure • Liver failure • Gender • Route and time of administration • Pregnancy • Tolerance • Addiction • Nutrients • Genetics • Presence of other drugs in the body women are more sensitive to drugs that affect the central nervous system and to alcohol fatty foods delays absorb of drugs DRUG INTERACTIONS 1. Pharmacodynamic interactions • Pharmacodynamic interactions occur between drugs that act on the same receptor. • One drug can increase or decrease the effect of another drug by changing its site of action. • Accordingly, two situations, antagonism or synergism, may occur. DRUG INTERACTIONS Interactions in the same direction ➢ Additive effect (Summation) ➢ Synergism and potentiation ❑ Opposite interactions ➢ Antagonism • Chemical • Physiological • Pharmacological ➢ Pharmaceutical incompatibility Result of drug interaction: - Increases the effect - Decreses the effect -A new effect appears TYPES OF INTERACTION Additive effect: 1 + 1 = 2 Synergistic effect: 1 + 1 > 2 Potentialization: 1 + 0 = 2 Antagonism: 1 – 1 = 0 or 0.5 Antagonism: • When a drug (antagonist) prevents or eliminates the effect of another drug (agonist), this is called antagonism. • This reaction is used in cases of poisoning with various drugs and poisons. (antidote, antidote) Antagonism: 1 – 1 = 0 or 0.5 2. Pharmacokinetic interactions 3. Pharmaceutical interactions • When one drug changes the absorption, distribution, metabolism and excretion of another drug, it is called a pharmacokinetic drug interaction. • Medicines can interact outside the body even before they enter the body. This is also called incompatibility. • Example: Precipitation or color change occurs when two drugs in liquid form are mixed. • These types of drugs should not be administered together at the same time, and mixing two drugs in the same syringe should be avoided. • For example, during the treatment of tetracycline and ampicillin, the effect of oral contraceptive (contraceptive) drugs decreases and unwanted pregnancy may occur. FACTORS AFFECTING DRUG INTERACTIONS Dose Route of administration Characteristics of concomitant drugs Patient characteristics Drugs that most frequently cause interactions in the emergency department: • Theophylline • Macrolide group antibiotics • Digital glycosides • Nonsteroidal anti-inflammatories • ACE inhibitors • Calcium channel blockers CHANGES IN SENSITIVITY TO DRUGS • ❑ Tolerance • ❑ Tachyphylaxis • ❑ Addiction • ❑ Drug allergy TOLERANCE: TASIFLAXY: • It is the gradual decrease in the potency of a drug after a certain period of use or congenital insensitivity of individuals to a drug. • It is a situation where tolerance emerges quickly. • It occurs over a period of minutes measured by successive administration of drug doses. • Tolerance to morphine • Meperidin • metadon ADDICTION: • With continuous or periodic intake of drugs or substances that have the potential to cause addiction, an irresistible physical or psychic desire for that drug / substance and the occurrence of withdrawal / withdrawal symptoms in the absence of the drug is called "substance addiction". DRUG ALLERGY: • It is a situation in which a drug produces unusual effects in the person as a result of immunological reactions. • Drug allergy is not related to the dose applied!! • Personal sensitivity and drug structure play an important role in allergy. An 18-year-old female patient is brought to the Which of the following routes of administration is Drug A is a weakly basic drug with a pKa of 7.8. If administered orally, at which of the following sites of absorption will the drug be able to readily pass through the membrane? the most desirable for administering the antidote • A. Mouth (pH approximately 7.0) for the drug overdose? • B. Stomach (pH of 2.5) • A. Intramuscular • C. Duodenum (pH approximately 6.1) • B. Intravenous • D. Jejunum (pH approximately 8.0) • C. Oral • E. Ileum (pH approximately 7.0) emergency department due to drug overdose. • D. Subcutaneous • E. Transdermal Which of the following reactions represents Phase II of drug metabolism? • A. Amidation • B. Hydrolysis • C. Oxidation • D. Reduction • E. Sulfation All are criteria for selection of essential drugs EXCEPT A. Pattern of prevalent diseases • B. The training and experience of available • personnel • C. Treatment facilities • D. Relative efficacy, cost, and suitability • E. Latest drug in the market